186 related articles for article (PubMed ID: 12445803)
1. Cerebrospinal fluid and serum protein levels of tumour necrosis factor-alpha (TNF-alpha) interleukin-6 (IL-6) and soluble interleukin-6 receptor (sIL-6R gp80) in multiple sclerosis patients.
Vladić A; Horvat G; Vukadin S; Sucić Z; Simaga S
Cytokine; 2002 Oct; 20(2):86-9. PubMed ID: 12445803
[TBL] [Abstract][Full Text] [Related]
2. IL-6 and sIL-6R concentration in the cerebrospinal fluid and serum of MS patients.
Stelmasiak Z; Kozioł-Montewka M; Dobosz B; Rejdak K
Med Sci Monit; 2001; 7(5):914-8. PubMed ID: 11535934
[TBL] [Abstract][Full Text] [Related]
3. CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis.
Padberg F; Feneberg W; Schmidt S; Schwarz MJ; Körschenhausen D; Greenberg BD; Nolde T; Müller N; Trapmann H; König N; Möller HJ; Hampel H
J Neuroimmunol; 1999 Oct; 99(2):218-23. PubMed ID: 10505978
[TBL] [Abstract][Full Text] [Related]
4. Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseases.
Michalopoulou M; Nikolaou C; Tavernarakis A; Alexandri NM; Rentzos M; Chatzipanagiotou S; Cambouri C; Vassilopoulos D
Immunol Lett; 2004 Jul; 94(3):183-9. PubMed ID: 15275965
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease. Results of a pilot study.
Bagli M; Papassotiropoulos A; Hampel H; Becker K; Jessen F; Bürger K; Ptok U; Rao ML; Möller HJ; Maier W; Heun R
Eur Arch Psychiatry Clin Neurosci; 2003 Feb; 253(1):44-8. PubMed ID: 12664314
[TBL] [Abstract][Full Text] [Related]
6. Increased serum levels of non-collagenous matrix proteins (cartilage oligomeric matrix protein and melanoma inhibitory activity) in marathon runners.
Neidhart M; Müller-Ladner U; Frey W; Bosserhoff AK; Colombani PC; Frey-Rindova P; Hummel KM; Gay RE; Häuselmann H; Gay S
Osteoarthritis Cartilage; 2000 May; 8(3):222-9. PubMed ID: 10806050
[TBL] [Abstract][Full Text] [Related]
7. Notable increased cerebrospinal fluid levels of soluble interleukin-6 receptors in neuromyelitis optica.
Wang H; Wang K; Zhong X; Dai Y; Qiu W; Wu A; Hu X
Neuroimmunomodulation; 2012; 19(5):304-8. PubMed ID: 22777162
[TBL] [Abstract][Full Text] [Related]
8. Analysis of soluble interleukin 6 receptor in cerebrospinal fluid in inflammatory and non-inflammatory conditions.
Azuma H; Moriyama T; Ikeda H; Oshima M; Okuno A; Sekiguchi S
Cytokine; 2000 Feb; 12(2):160-4. PubMed ID: 10671302
[TBL] [Abstract][Full Text] [Related]
9. Serum and CSF levels of IL-2, sIL-2R, TNF-alpha, and IL-1 beta in chronic progressive multiple sclerosis: expected lack of clinical utility.
Peter JB; Boctor FN; Tourtellotte WW
Neurology; 1991 Jan; 41(1):121-3. PubMed ID: 1985276
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis.
Robak T; Gladalska A; Stepień H; Robak E
Mediators Inflamm; 1998; 7(5):347-53. PubMed ID: 9883970
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of interferon-gamma, tumour necrosis factor-alpha, soluble interleukin-6R and soluble cell activation markers for monitoring response to treatment of leprosy reactions.
Iyer A; Hatta M; Usman R; Luiten S; Oskam L; Faber W; Geluk A; Das P
Clin Exp Immunol; 2007 Nov; 150(2):210-6. PubMed ID: 17937676
[TBL] [Abstract][Full Text] [Related]
12. Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis.
Maimone D; Gregory S; Arnason BG; Reder AT
J Neuroimmunol; 1991 Apr; 32(1):67-74. PubMed ID: 2002092
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission.
Robak T; Wierzbowska A; Błasińska-Morawiec M; Korycka A; Błoński JZ
Mediators Inflamm; 1999; 8(6):277-86. PubMed ID: 10815616
[TBL] [Abstract][Full Text] [Related]
14. Elevated levels of interleukin-2, soluble interleukin-2 receptor alpha, interleukin-6, soluble interleukin-6 receptor and vascular endothelial growth factor in serum and ascitic fluid of patients with severe ovarian hyperstimulation syndrome.
Aboulghar MA; Mansour RT; Serour GI; El Helw BA; Shaarawy M
Eur J Obstet Gynecol Reprod Biol; 1999 Nov; 87(1):81-5. PubMed ID: 10579621
[TBL] [Abstract][Full Text] [Related]
15. Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking.
Salvi M; Pedrazzoni M; Girasole G; Giuliani N; Minelli R; Wall JR; Roti E
Eur J Endocrinol; 2000 Aug; 143(2):197-202. PubMed ID: 10913938
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 6 and its soluble receptor are elevated in aqueous humor of patients with uveitis.
Petrinović-Doresić J; Mazuran R; Henc-Petrinović L; Kuzmanović B; Jovicić A
Ocul Immunol Inflamm; 1999 Jun; 7(2):75-84. PubMed ID: 10420202
[TBL] [Abstract][Full Text] [Related]
17. Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma.
Urbańska-Ryś H; Wiersbowska A; Stepień H; Robak T
Eur Cytokine Netw; 2000 Sep; 11(3):443-51. PubMed ID: 11022130
[TBL] [Abstract][Full Text] [Related]
18. Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it inhibits TNF production.
Igaz P; Horváth A; Horváth B; Szalai C; Pállinger E; Rajnavölgyi E; Tóth S; Rose-John S; Falus A
Immunol Lett; 2000 Mar; 71(3):143-8. PubMed ID: 10722865
[TBL] [Abstract][Full Text] [Related]
19. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
[TBL] [Abstract][Full Text] [Related]
20. [Soluble cytokinin receptors in renal vasculitis and lupus nephritis].
Tesar V; Jirsa M; Masek Z; Bartůnková J; Stejskalová A; Dostál C; Zabka J; Chábová V; Rysavá R
Cas Lek Cesk; 1998 May; 137(9):271-5. PubMed ID: 9650355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
